EPN vs NYR

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

EPN

EPSILON FPO [EPN]

39LOW

NYR

NYRADA CDI FORUS [NYR]

52MEDIUM

Score Breakdown

EPN NYR
Technical
61
47
Catalyst
66
49
Sentiment
50
50
Fundamental
53
46
Momentum
60
67
Risk Gate
37
42

Key Metrics

EPN Metric NYR
$8.6MMarket Cap$101.3M
85KAvg Volume (20d)185K
N/AShort InterestN/A
$0.04052-Week High$1.435
$0.01952-Week Low$0.225
+0.0%Daily Change-2.4%
$0.022Reference Price$0.400
N/AROE-71.0%
-13.6%Profit Margin-234.3%

Active Signals

EPN Signals

Stochastic is deep in oversold territory — bounce conditions forming
Bollinger Bands are tightening — volatility is coiling up for a potential breakout
Sitting near support — this level has held before and could attract buyers again
Volume-price trend suggests distribution — sellers may be sneaking out while price holds
Volatility is contracting — like a spring being compressed, breakouts often follow
Below the 200-day average — the long-term trend is still working against it
Critical cash runway (0.3 quarters)
Low P/S ratio (0.9x)

NYR Signals

RSI drifting toward oversold territory — worth watching
Trading below both moving averages — the trend is working against this one
Sitting near support — this level has held before and could attract buyers again
Drifting lower — down 4.8% over the last 5 days
Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
Below the 200-day average — the long-term trend is still working against it
Low cash runway (4 quarters) - dilution risk
Piotroski F-Score weak (3/9, low-confidence approx)

Ask Scout AI to compare EPN and NYR in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

EPN vs PTX →EPN vs RAD →EYE vs IMM →EYE vs LDX →EYE vs PNV →
EPN Full Analysis → NYR Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).